- Home
- SBFM vs FRSX Comparison
SBFM vs FRSX Comparison
Compare SBFM & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- FRSX
- Stock Information
- Founded
- SBFM 2006
- FRSX N/A
- Country
- SBFM United States
- FRSX Israel
- Employees
- SBFM N/A
- FRSX N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- FRSX Computer Software: Prepackaged Software
- Sector
- SBFM Health Care
- FRSX Technology
- Exchange
- SBFM Nasdaq
- FRSX Nasdaq
- Market Cap
- SBFM 6.7M
- FRSX 7.1M
- IPO Year
- SBFM N/A
- FRSX 2017
- Fundamental
- Price
- SBFM $1.67
- FRSX $2.23
- Analyst Decision
- SBFM Strong Buy
- FRSX
- Analyst Count
- SBFM 1
- FRSX 0
- Target Price
- SBFM $15.00
- FRSX N/A
- AVG Volume (30 Days)
- SBFM 62.2K
- FRSX 72.5K
- Earning Date
- SBFM 11-04-2025
- FRSX 09-21-2025
- Dividend Yield
- SBFM N/A
- FRSX N/A
- EPS Growth
- SBFM N/A
- FRSX N/A
- EPS
- SBFM N/A
- FRSX N/A
- Revenue
- SBFM $36,341,741.00
- FRSX $452,000.00
- Revenue This Year
- SBFM $32.20
- FRSX N/A
- Revenue Next Year
- SBFM $32.74
- FRSX N/A
- P/E Ratio
- SBFM N/A
- FRSX N/A
- Revenue Growth
- SBFM 19.22
- FRSX N/A
- 52 Week Low
- SBFM $1.17
- FRSX $1.98
- 52 Week High
- SBFM $3.90
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- SBFM 67.82
- FRSX 64.94
- Support Level
- SBFM $1.50
- FRSX $2.06
- Resistance Level
- SBFM $1.67
- FRSX $2.30
- Average True Range (ATR)
- SBFM 0.08
- FRSX 0.12
- MACD
- SBFM 0.01
- FRSX -0.06
- Stochastic Oscillator
- SBFM 73.44
- FRSX 55.01
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.